1. Home
  2. ANVS vs KORE Comparison

ANVS vs KORE Comparison

Compare ANVS & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • KORE
  • Stock Information
  • Founded
  • ANVS 2008
  • KORE 2003
  • Country
  • ANVS United States
  • KORE United States
  • Employees
  • ANVS N/A
  • KORE N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • ANVS Health Care
  • KORE Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • KORE Nasdaq
  • Market Cap
  • ANVS 54.6M
  • KORE 45.0M
  • IPO Year
  • ANVS 2020
  • KORE N/A
  • Fundamental
  • Price
  • ANVS $2.64
  • KORE $2.30
  • Analyst Decision
  • ANVS Strong Buy
  • KORE Hold
  • Analyst Count
  • ANVS 5
  • KORE 2
  • Target Price
  • ANVS $30.25
  • KORE $2.75
  • AVG Volume (30 Days)
  • ANVS 570.5K
  • KORE 16.0K
  • Earning Date
  • ANVS 08-14-2025
  • KORE 08-14-2025
  • Dividend Yield
  • ANVS N/A
  • KORE N/A
  • EPS Growth
  • ANVS N/A
  • KORE N/A
  • EPS
  • ANVS N/A
  • KORE N/A
  • Revenue
  • ANVS N/A
  • KORE $282,254,000.00
  • Revenue This Year
  • ANVS N/A
  • KORE $4.66
  • Revenue Next Year
  • ANVS N/A
  • KORE $6.71
  • P/E Ratio
  • ANVS N/A
  • KORE N/A
  • Revenue Growth
  • ANVS N/A
  • KORE N/A
  • 52 Week Low
  • ANVS $1.11
  • KORE $1.10
  • 52 Week High
  • ANVS $17.88
  • KORE $4.88
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 54.28
  • KORE 44.65
  • Support Level
  • ANVS $2.73
  • KORE $2.22
  • Resistance Level
  • ANVS $3.08
  • KORE $2.49
  • Average True Range (ATR)
  • ANVS 0.32
  • KORE 0.19
  • MACD
  • ANVS -0.06
  • KORE -0.02
  • Stochastic Oscillator
  • ANVS 29.41
  • KORE 12.13

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: